Acute Porphyria Drug Database

Monograph

A06AD17 - Sodium Phosphate
Not porphyrinogenic
NP

Rationale
Sodium phosphate is a salt that is eliminated by the kidneys, with no hepatic involvement.
Chemical description
Sodium phosphate a salt of sodium and phosphoric acid.
Therapeutic characteristics
Sodium phosphate is an osmotically acting laxative. Concentrated oral solutions are used for bowel cleansing before surgery or endoscopy procedures. The oral solutions act within 30 minutes to 6 hours. Common adverse reactions of sodium phosphate that can be confused with an acute porphyric attack are nausea, vomiting, diarrhoea, and abdominal pain.
Metabolism and pharmacokinetics
About two-thirds of ingested phosphate is absorbed from the gastrointestinal tract. Excess phosphate is mainly excreted in the urine, the remainder being excreted in the faeces. No hepatic involvement.
IPNet drug reports
No.
Similar drugs
Explore alternative drugs in similar therapeutic classes A06A / A06AD or go back.

References

# Citation details PMID
*Drug reference publications
1. Sweetman SC, editor. Martindale: The complete drug reference. Phosphate. Pharmaceutical Press 2009.
*Summary of Product Characteristics
2. Norwegian medicines agency. Summary of Product Characteristics (SPC). Phosphoral.

Tradenames
This list comprises raw data collected from different countries. In some cases, a more comprehensive list of available drug packages is included. Consequently, very similar terms may therefore appear multiple times. Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.


Phosphoral Fosfosoda · Mayprep Phospho-soda · Sodium dihydrogen Phosphoral Coloclear Cleen Phospho-Soda Phosphoral
 
© NAPOS 2025
An unhandled error has occurred. Reload 🗙